Seres Therapeutics IncMCRB
Price$2.93

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value not published yet, our data-reliability standards weren't met; method estimates belowbased on filings through 30 Jun 2026
Market Price $2.93Price as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 7.2%
Volatility vs market (adjusted beta)0.49

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetSeres Therapeutics IncMCRBHealth Care
Valuation
P/E—
P/S21.3×
P/B1.1×
EV / Revenue13.1×
EV / EBITDA-1.9×
Profitability
Gross margin100.0%
Operating margin-5,849.7%
Net margin-1,192.9%
FCF margin-2,724.1%
Returns
ROE-65.0%
ROA-22.1%
ROIC—
Growth
Revenue growth (YoY)—
5-yr fwd EPS growth—
Financial strength
Debt / Equity—
Current ratio2.11×
Altman Z-Score-15.7
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.